Ingredient Listby KAL

KAL C 1000+, Sustained Release, 250 Tablets

4.9(43 ratings)

UPC: 021245562238

$31.29
$1.04 / serving · 30 servings
Buy on iHerb

KAL's C 1000+ Sustained Release is a vitamin C supplement designed to provide extended immune support through a timed-release formula. Each tablet delivers 1,000 mg of ascorbic acid, complemented by rose hips and a blend of citrus bioflavonoids, hesperidin, and rutin, which are included for their antioxidant properties.

This product uses a sustained-release mechanism to gradually release vitamin C over time, aiming for consistent nutrient delivery. The manufacturer notes it is formulated to support immune health, with ingredients like bioflavonoids added for enhanced antioxidant activity. It is available in a 250-tablet package and comes in tablet form, also offered in a 100-count variant. Certifications include Non-GMO, Vegan, and Gluten-Free.

At a glance

Trust Quality Since 19321 DailyImmune System SupportNon GMOVeganGluten FreeDietary Supplement

Supplement Facts

Serving Size: 1 Tablet
IngredientAmount Per Serving% Daily Value
Vitamin C (as Ascorbic Acid)1,000 mg1,111%
Rose Hips20 mg*
Bioflavonoid Concentrate (from Citrus)10 mg*
Hesperidin Concentrate10 mg*
Rutin Concentrate10 mg*
† Daily Value not established

Other Ingredients

Cellulose, silica, guar gum, stearic acid and magnesium stearate.

Warnings
Contains magnesium stearate (may not be vegan)
Positives
No artificial colors or flavors detectedNo common allergens

Certifications & Claims

Non-GMOVeganGluten-Free

Label Information

Directions, warnings, and other information directly from the product label.

Suggested Use

Take 1 tablet daily with a meal or glass of water. Us only as directed

Warning

Don not us if safety seal is broken or missing. Keep out if reach of children. Keep your licensed health care practitioner informed when using this product.Store in a cool, dry place.

Product Info

Brand
KAL
UPC
021245562238
Package Qty
250 count
Dimensions
6.4 x 3.1 x 3.1 in
Shipping Weight
0.95 lb
First Available
05/2023